| 标题 |
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Frontiers in Neurology 作者:James F. Howard; Vera Bril; Tuan Vu; Chafic Karam; Stojan Perić; et al 出版日期:2024-01-17 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)